Gilead Sciences Inc. (GILD)
Market Closed
16 Oct, 08:00 PM
$
156. 19
-1.18
-0.7498%
$
187.44B Market Cap
17.2 P/E Ratio
0.42% Div Yield
7.77M Volume
6.22 Eps
$ 157.37
Previous Close 
Want to track GILD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gilead Sciences Inc. (GILD) Statistics
Valuation metrics
Market Cap 187.44B
Enterprise value 216.74B
Trailing P/E (ttm) -60.07
Forward P/E 13.58
PEG ratio 0.4
Price/Sales (ttm) 6.36
Price/Book (mrq) 16.41
Enterprise Value/Revenue 7.12
Enterprise Value/EBITDA 162.47
Overview
Shares outstanding 1.24B
Float 1.24B
Shares short 22.75M
% Held by insiders 0%
% Held by institutions 0.95%
Average volume (10 days) 6.07M
Average volume (90 days) 6.04M
Price summary
52-Week low 114.02
52-Week high 160.51
Beta 0.33
50-Day moving average 149.01
200-Day moving average 137.26
Dividends and splits
Forward annual dividend rate 3.28
Forward annual dividend yield 0.0246%
Trailing annual dividend rate 3.25
Trailing annual dividend yield 0.0208%
5-Year annual dividend yield 3.65%
Payout ratio -1.26
Dividend Date 29 Sep 2026
Ex-Dividend Date 15 Sep 2026
Last split factor 2:1
Last split Date 28 Jan 2013
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.11%
Operating margin -0.05%
Operational effectiveness
Return on assets -0.07%
Return on equity -0.16%
Income Statement
Revenue (ttm) 29.74B
Revenue per share (ttm) 24.5
Quarterly revenue growth (yoy) 0.04%
Gross profit (ttm) 23.6B
EBITDA 14.81B
Net income to common (ttm) 9.22B
Diluted EPS (ttm) -2.61
Quarterly earnings growth (yoy) 0.54%
Balance Sheet
Total cash (mrq) 9.82B
Total cash per share (mrq) 2.56
Total debt (mrq) 22.17B
Total Debt/Equity (mrq) 2.22
Current ratio (mrq) 1.27%
Book value per share (mrq) 9.45
Cash Flow
Cash flow statement 10.81B
Levered free cash flow (LFCF) 7.93B
2026 © Marketlog. All Rights Reserved.
